26 related articles for article (PubMed ID: 27633091)
1. Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity.
Tubeleviciute-Aydin A; Zhou L; Sharma G; Soni IV; Savinov SN; Hardy JA; LeBlanc AC
Sci Rep; 2018 Mar; 8(1):4428. PubMed ID: 29535332
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Efficacy of Arylquin 1 through Dose-Dependent Cytotoxicity, Apoptosis Induction, and Synergy with Radiotherapy in Glioblastoma Models.
Lieu AS; Pan YC; Lee JH; Hsieh YC; Lin CJ; Hsu YL; Chang KC; Kuo SH; Tseng TT; Tsai HP
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672261
[TBL] [Abstract][Full Text] [Related]
3. Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG.
Shilova ON; Proshkina GM; Lebedenko EN; Deyev SM
Acta Naturae; 2015; 7(3):126-32. PubMed ID: 26483969
[TBL] [Abstract][Full Text] [Related]
4. LPS Upregulated VEGFR-3 Expression Promote Migration and Invasion in Colorectal Cancer via a Mechanism of Increased NF-κB Binding to the Promoter of VEGFR-3.
Zhu G; Huang Q; Zheng W; Huang Y; Hua J; Yang S; Zhuang J; Wang J; Chang J; Xu J; Ye J
Cell Physiol Biochem; 2016; 39(5):1665-1678. PubMed ID: 27639612
[TBL] [Abstract][Full Text] [Related]
5. Combined SRC inhibitor saracatinib and anti-ErbB2 antibody H2-18 produces a synergistic antitumor effect on trastuzumab-resistant breast cancer.
Wang L; Yu X; Dong J; Meng Y; Yang Y; Wang H; Wang C; Zhang Y; Zhao Y; Zhao J; Wang H; Lu C; Li B
Biochem Biophys Res Commun; 2016 Oct; 479(3):563-570. PubMed ID: 27666484
[TBL] [Abstract][Full Text] [Related]
6. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1.
Wang Y; Yu S; Huang D; Cui M; Hu H; Zhang L; Wang W; Parameswaran N; Jackson M; Osborne B; Bedogni B; Li C; Sy MS; Xin W; Zhou L
Am J Pathol; 2016 Nov; 186(11):2945-2956. PubMed ID: 27639164
[TBL] [Abstract][Full Text] [Related]
7. Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies.
D'Souza NM; Fang P; Logan J; Yang J; Jiang W; Li J
Front Oncol; 2016; 6():212. PubMed ID: 27774435
[TBL] [Abstract][Full Text] [Related]
8. Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A; Heilinger T; Lavelle EC; Prehn JH
J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
[TBL] [Abstract][Full Text] [Related]
9. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.
Kamran N; Chandran M; Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():34-42. PubMed ID: 27777083
[TBL] [Abstract][Full Text] [Related]
10. Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.
Sengupta S; Mao G; Gokaslan ZS; Sampath P
Cancer Gene Ther; 2017 Mar; 24(3):121-129. PubMed ID: 27767090
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma.
Tseng HJ; Banerjee S; Qian B; Lai MJ; Wu TY; Hsu TI; Lin TE; Hsu KC; Chuang KH; Liou JP; Shih JC
Eur J Med Chem; 2023 Aug; 256():115459. PubMed ID: 37172473
[TBL] [Abstract][Full Text] [Related]
12. CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment.
Guo K; Zhao J; Jin Q; Yan H; Shi Y; Zhao Z
Front Oncol; 2022; 12():818283. PubMed ID: 36119521
[TBL] [Abstract][Full Text] [Related]
13. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
14. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
[TBL] [Abstract][Full Text] [Related]
15. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S
Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073
[TBL] [Abstract][Full Text] [Related]
16. A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma.
Zhou BG; Liu MY; Qiu XC; Xu YM; Fan QY; Yang AG; Zhang Y; Xia H
Oncol Rep; 2013 Jan; 29(1):276-82. PubMed ID: 23135254
[TBL] [Abstract][Full Text] [Related]
17. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
18. HER2-targeted recombinant protein immuno-caspase-6 effectively induces apoptosis in HER2-overexpressing GBM cells in vitro and in vivo.
Zhang L; Ren J; Zhang H; Cheng G; Xu Y; Yang S; Dong C; Fang D; Zhang J; Yang A
Oncol Rep; 2016 Nov; 36(5):2689-2696. PubMed ID: 27633091
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
